Alcuronium

Discover <strong>Alcuronium</strong>, a non-depolarizing muscle relaxant. Learn about its medical uses in anesthesia, mechanism of action, dosage, and pote

Alcuronium Alcuronium uses Alcuronium mechanism of action Alcuronium side effects Alcuronium dosage non-depolarizing muscle relaxant neuromuscular blocker anesthesia muscle relaxant surgical muscle relaxation
🏷 ATC Code: M03AC02 📂 Other peripherally acting muscle relaxants 🕐 Updated: Mar 13, 2026 ✓ Medical Reference

Looking to order Alcuronium?

Browse our catalog for available pharmaceutical products and competitive pricing.

What is Alcuronium?

Alcuronium is a medication primarily used in clinical settings as a muscle relaxant. Specifically, it belongs to the class of drugs known as non-depolarizing muscle relaxants or neuromuscular blockers. Derived from the alcuronium chloride, it is an isoquinoline alkaloid. Its main function is to induce temporary paralysis of skeletal muscles, a critical requirement during various surgical procedures and medical interventions. While historically significant, its use has become less common with the introduction of newer agents, but understanding its properties remains vital in pharmacology and anesthesiology. It is administered via intravenous administration and acts to facilitate endotracheal intubation and provide muscle relaxation throughout the duration of an operation.

How Does it Work?

The mechanism of action of Alcuronium involves its interaction with the neuromuscular junction. This is the specialized synapse where motor neurons communicate with muscle fibers. At this junction, the neurotransmitter acetylcholine binds to specific acetylcholine receptors on the muscle cell membrane, triggering muscle contraction. Alcuronium acts as a competitive antagonist at these nicotinic acetylcholine receptors. This means it binds to the same receptor sites as acetylcholine but does not activate them. By occupying these sites, Alcuronium prevents acetylcholine from binding and initiating muscle contraction. The result is a dose-dependent flaccid paralysis of skeletal muscles. Its onset of action is relatively rapid, typically within 2-3 minutes, and its duration of action is intermediate, lasting approximately 20-30 minutes, depending on the dose and individual patient factors. The effects can be reversed by administering anticholinesterase drugs, which increase the concentration of acetylcholine in the synaptic cleft, allowing it to outcompete Alcuronium for receptor binding.

Medical Uses

Alcuronium has been primarily employed in the field of anesthesia and critical care. Its main medical uses include:

  • Facilitating Endotracheal Intubation: By relaxing the muscles of the larynx and pharynx, Alcuronium makes it easier and safer to insert an endotracheal tube into the trachea, which is essential for mechanical ventilation during surgery.
  • Providing Skeletal Muscle Relaxation During Surgery: For many surgical procedures, particularly those involving the abdomen or chest, complete muscle relaxation is necessary to provide the surgeon with a clear and still operating field. Alcuronium helps achieve this by paralyzing the skeletal muscles.
  • Assisting Mechanical Ventilation: In critically ill patients who require mechanical ventilation, Alcuronium can be used to improve ventilator synchrony and reduce oxygen consumption by preventing spontaneous breathing efforts and muscle spasms.
  • Managing Convulsive States: In certain severe convulsive disorders, Alcuronium may be used to temporarily paralyze muscles and prevent physical injury, though this is a less common application.

It is important to note that Alcuronium only paralyzes muscles and does not have any analgesic (pain-relieving) or sedative properties. Therefore, it must always be administered in conjunction with adequate anesthesia and sedation to ensure patient comfort and prevent awareness during paralysis.

Dosage

The dosage of Alcuronium is highly individualized and must be determined by an experienced anesthesiologist or critical care physician. It depends on several factors, including:

  • Patient's weight and age
  • Renal function, as Alcuronium is primarily excreted by the kidneys
  • Type and duration of the surgical procedure
  • Concomitant medications
  • Desired depth and duration of muscle relaxation

Typically, Alcuronium is administered as an initial intravenous bolus, followed by maintenance doses or a continuous infusion if prolonged relaxation is required. Neuromuscular monitoring, using a peripheral nerve stimulator, is crucial to assess the depth of blockade and guide dosing, ensuring optimal muscle relaxation while minimizing the risk of prolonged paralysis. Reversal agents, such as neostigmine, are often used at the end of a procedure to restore muscle function.

Side Effects

Like all medications, Alcuronium can cause side effects, although not everyone experiences them. The most common side effects are related to its pharmacological action and potential histamine release:

  • Cardiovascular Effects: Hypotension (low blood pressure) and bradycardia (slow heart rate) can occur, although Alcuronium is generally considered to have less significant cardiovascular effects compared to some other neuromuscular blockers.
  • Histamine Release: While less pronounced than with some other agents (e.g., tubocurarine), Alcuronium can cause some histamine release, which may manifest as flushing, skin rash, or, in rare cases, bronchospasm or anaphylaxis.
  • Prolonged Muscle Weakness or Paralysis: This is a significant concern, especially in patients with impaired renal function or those receiving high doses. It can lead to delayed recovery of muscle strength and respiratory depression.
  • Allergic Reactions: Severe allergic reactions, including anaphylaxis, are rare but possible.

Close monitoring of vital signs and neuromuscular function is essential during and after Alcuronium administration to promptly identify and manage any adverse reactions.

Drug Interactions

Alcuronium can interact with various other medications, potentially altering its effects or the effects of the interacting drugs. Key drug interactions include:

  • Inhaled Anesthetics: Volatile anesthetics (e.g., isoflurane, sevoflurane) can potentiate the effects of Alcuronium, meaning a lower dose of Alcuronium may be required.
  • Other Neuromuscular Blockers: Concurrent administration with other neuromuscular blockers can lead to additive or synergistic effects, resulting in profound and prolonged paralysis.
  • Antibiotics: Certain antibiotics, particularly aminoglycosides (e.g., gentamicin, amikacin) and polymyxins, can enhance the neuromuscular blocking effects of Alcuronium.
  • Magnesium Salts: Magnesium can potentiate neuromuscular blockade, requiring careful dose adjustment.
  • Lithium: Lithium can prolong the duration of action of Alcuronium.
  • Diuretics: Furosemide can enhance or diminish the effect, depending on the patient's electrolyte status.
  • Anticholinesterases: Drugs like neostigmine and pyridostigmine, used to reverse neuromuscular blockade, directly antagonize the effects of Alcuronium.

It is crucial for medical professionals to be aware of a patient's full medication history to prevent adverse drug interactions and ensure patient safety.

FAQ

Is Alcuronium still commonly used today?

While historically important, Alcuronium is less commonly used in modern clinical practice compared to newer, more widely adopted non-depolarizing muscle relaxants such as rocuronium, vecuronium, or cisatracurium. This is partly due to the availability of agents with more predictable pharmacokinetics and fewer potential side effects like histamine release.

How is Alcuronium administered?

Alcuronium is administered intravenously (into a vein) by a healthcare professional in a controlled medical environment, typically in an operating room or intensive care unit.

What is the difference between Alcuronium and succinylcholine (suxamethonium)?

Alcuronium is a non-depolarizing muscle relaxant, meaning it competitively blocks acetylcholine receptors without activating them. Succinylcholine, on the other hand, is a depolarizing muscle relaxant; it initially activates the receptors, causing transient muscle fasciculations, before leading to sustained depolarization and paralysis. They have different mechanisms of action, durations, and side effect profiles.

Can Alcuronium cause allergic reactions?

Yes, like many drugs, Alcuronium can cause allergic reactions. Although less common than with some other muscle relaxants, it can induce histamine release, which may lead to symptoms ranging from skin flushing and rash to more severe anaphylactic reactions in susceptible individuals.

Products containing Alcuronium are available through trusted online pharmacies. You can browse Alcuronium-based medications at ShipperVIP or Medicenter.

Summary

Alcuronium is an intermediate-acting non-depolarizing muscle relaxant that plays a historical role in anesthesia and critical care. It functions by competitively blocking acetylcholine receptors at the neuromuscular junction, leading to skeletal muscle paralysis. Its primary uses include facilitating endotracheal intubation and providing muscle relaxation during surgical procedures. While generally well-tolerated, potential side effects such as hypotension and histamine release, along with various drug interactions, necessitate careful dosing and monitoring. Although newer neuromuscular blockers are now more prevalent, understanding Alcuronium's pharmacology remains valuable for healthcare professionals.